Reserved area

Credentials and contents in the EryDel “RESERVED AREA” are strictly confidential and the access is authorized only for the medical staff operating the EDS in the ATTeST study. The Content of the “RESERVED AREA” should not be copied, distributed or reproduced in whole or in part, nor distributed to any third party if not for the  training purpose of authorized EDS Operators. The Content of the “RESERVED AREA” is only for medically trained staff.

I Agree

Development Team 

Ravi Anand, MD, Consultant, Clinical & Regulatory. Former Head CNS Medical Affair at Novartis, Roche, Organon. 

Patricia Salvati, Consultant, Preclinical development. Former VP Preclinical Development at Newron, Pharmacia-Upjohn.

David Prentice, PhD, Preclinical Safety. Founder PCS consulting, former Head of Pathology, Huntingdon and Sandoz.

Walter Dieterle, PhD, DMPK. PCS Consulting, former global Head of Bioanalytics and Pharmacokinetcs Ciba-Geigy/Novartis

Sally Look, PhD, CMC. President and founder of Interlink, former FDA (CDER) reviewing chemist. 

Richard A. Vogel, PhD, MBA Vogel Regulatory Consulting LLC. Former consultant at CliniRX USA, ex MSD, Sandoz/Novartis, Eisai, PRA

Richard Hartman, PhD, Clinical Scientist, Medical Writer. Sandoz/ Novartis, i3 

Munaf Ali, PhD, Regulatory EMA. Former MHRA, UK

Where We Are